Rajeev Sharma

Dr. Rajeev Sharma

University of Nevada Las Vegas

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2010 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
RKRandeep Kashyap
Randeep Kashyap
SSSaman Safadjou
Saman Safadjou
RCRui Chen
Rui Chen
PMParvez Mantry
Parvez Mantry
RSRajeev Sharma
Rajeev Sharma
MOMark Orloff
Mark Orloff

1 August 2009 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
RKRandeep Kashyap
Randeep Kashyap
PMParvez Mantry
Parvez Mantry
RSRajeev Sharma
Rajeev Sharma
MMManoj K. Maloo
Manoj K. Maloo
SSSaman Safadjou
Saman Safadjou
MOMark Orloff
Mark Orloff

1 August 2020 in International Journal of Nephrology and Renovascular Disease
Verified
Journal Article
Open access
PDF file
RSRajeev Sharma
Rajeev Sharma
MZMareena Zachariah
Mareena Zachariah
BK virus reactivation as a result of therapeutic immunosuppression following renal transplant can result in BK polyomavirus nephropathy and renal allograft loss. This is a complex and challenging clinical problem with a range of management options and practices reported in literature. The current standard for early diagnosis and treatment is surveillance by measuring viral DNA in blood using qPCR. Immunosuppression reduction is the cornerstone of effective management but is associated with a risk of acute rejection following treatment.

15 June 2008 in Transplantation
Verified
Journal Article
Closed access
RKRandeep Kashyap
Randeep Kashyap
ABAdel Bozorgzadeh
Adel Bozorgzadeh
PAPeter Abt
Peter Abt
GTGeorgios Tsoulfas
Georgios Tsoulfas
MMManoj Maloo
Manoj Maloo
MOMark Orloff
Mark Orloff
Accurate preoperative assessment of biliary anatomy in live donor hepatectomy may be helpful to assess the suitability of a graft and to stratify risk of biliary complications. A retrospective review of existing data among donor and recipients of 36 living donor transplants was performed to assess role of preoperative magnetic resonance cholangiography (MRC) for defining biliary anatomy and to stratify risk of biliary complications. Thirty-six living liver donors underwent MRC, and subsequently right lobectomy. Intraoperative cholangiography and biliary exploration revealed that 24 donors (66.6%) had conventional and 12 (33.3%) had aberrant biliary anatomy. Intraoperative cholangiography demonstrated a strong correlation with MRC (P=0.001) and intraoperative findings (P=0.001). MRC had specificity and positive predictive value of 100%. The risk of developing biliary complication was 5.9 times higher if the biliary anatomy was of any type other than A (P=0.03, CI 1.06-32.9) after controlling for donor age, recipient age, and type of anastomosis. MRC reliably identified variant biliary anatomy. The preoperative MRC demonstrated congruence with the intraoperative cholangiogram and with the intraoperative findings. MRC is helpful in predicting risk of biliary complications in recipients, and identifies donors who would otherwise be excluded intraoperatively by cholangiography, thus limiting the risk of an unnecessary operation.

1 March 2010 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
RSRajeev Sharma
Rajeev Sharma
RKRandeep Kashyap
Randeep Kashyap
AJAshok Jain
Ashok Jain
SSSaman Safadjou
Saman Safadjou
MGMaureen Graham
Maureen Graham
MOMark Orloff
Mark Orloff

1 May 2008 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
DTDavid Tretheway
David Tretheway
AJAshok Jain
Ashok Jain
RLRandi LaPoint
Randi LaPoint
RSRajeev Sharma
Rajeev Sharma
MOMark Orloff
Mark Orloff
CRCharlotte Ryan
Charlotte Ryan
Recurrent hepatitis C is virtually universal after liver transplantation; however, an individual patient's clinical course and disease burden are highly variable and difficult to predict. The fibrosis score determined on posttransplant biopsies appears to be a sensitive and specific marker of disease progression and severity. Currently, the fibrosis score is determined from hematoxylin and eosin (H&E)–stained tissue sections supplemented by variable use of trichrome stain or other connective tissue–specific stains. In this study, we compare the fibrosis score on H&E stain with that obtained with trichrome stain in posttransplant liver biopsies of patients with hepatitis C. A total of 197 liver biopsies from 105 allograft patients with hepatitis C were reviewed. The mean fibrosis stage was 1.0 ± 1.25 with H&E stain versus 1.69 ± 1.42 with trichrome stain (P < 0.00001). The trichrome staging score was higher in 53.3%, lower in 3%, and the same in 43.7%. The fibrosis stage was raised by 2 or more points in 17.8% and elevated into a bridging category in 14.7%. No significant differences in clinical and laboratory levels were measured in patients with higher fibrosis scores. In conclusion, the hepatic fibrosis score is significantly underestimated by H&E stain in the posttransplant setting in patients with hepatitis C. The fibrosis stage may be an indicator of significant liver damage in these patients. Accuracy of its determination may be most easily facilitated by employment of a connective tissue stain. Liver Transpl 2008. © 2008 AASLD.